BRISTOL-MYERS SQUIBB ($BMY) posted quarterly earnings results for Q1 2026 on Thursday, April 30th. The company reported earnings of $1.58 per share, beating estimates of $1.42 by $0.16. The company also reported revenue of $11,489,000,000, beating estimates of $10,960,931,595 by $528,068,405.
You can see Quiver Quantitative's $BMY stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BRISTOL-MYERS SQUIBB Insider Trading Activity
BRISTOL-MYERS SQUIBB insiders have traded $BMY stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BMY stock by insiders over the last 6 months:
- DAVID V ELKINS (EVP, Chief Financial Officer) has made 0 purchases and 2 sales selling 30,000 shares for an estimated $1,850,016.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
BRISTOL-MYERS SQUIBB Hedge Fund Activity
We have seen 1,162 institutional investors add shares of BRISTOL-MYERS SQUIBB stock to their portfolio, and 1,121 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 65,718,198 shares (-75.4%) from their portfolio in Q4 2025, for an estimated $3,544,839,600
- AQR CAPITAL MANAGEMENT LLC added 16,332,924 shares (+172.6%) to their portfolio in Q4 2025, for an estimated $880,997,920
- CAPITAL INTERNATIONAL INVESTORS removed 11,395,497 shares (-35.2%) from their portfolio in Q4 2025, for an estimated $614,673,108
- JPMORGAN CHASE & CO removed 10,813,011 shares (-12.5%) from their portfolio in Q4 2025, for an estimated $583,253,813
- WELLINGTON MANAGEMENT GROUP LLP removed 10,234,541 shares (-59.7%) from their portfolio in Q4 2025, for an estimated $552,051,141
- MARSHALL WACE, LLP added 9,310,682 shares (+607.1%) to their portfolio in Q4 2025, for an estimated $502,218,187
- PACER ADVISORS, INC. removed 9,304,698 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $501,895,410
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
BRISTOL-MYERS SQUIBB Government Contracts
We have seen $8,921,817 of award payments to $BMY over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- REVLIMID, POMALYST, CAMZYOS SPECIALTY PHARMACEUTICALS: $848,445
- EMERGENCY BREYANZI INFUSION: $670,085
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
BRISTOL-MYERS SQUIBB Congressional Stock Trading
Members of Congress have traded $BMY stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BMY stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 2 purchases worth up to $30,000 on 12/19, 11/12 and 0 sales.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
BRISTOL-MYERS SQUIBB Analyst Ratings
Wall Street analysts have issued reports on $BMY in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/23/2026
- B of A Securities issued a "Buy" rating on 12/15/2025
- Guggenheim issued a "Buy" rating on 12/12/2025
To track analyst ratings and price targets for BRISTOL-MYERS SQUIBB, check out Quiver Quantitative's $BMY forecast page.
BRISTOL-MYERS SQUIBB Price Targets
Multiple analysts have issued price targets for $BMY recently. We have seen 15 analysts offer price targets for $BMY in the last 6 months, with a median target of $60.0.
Here are some recent targets:
- Tim Anderson from B of A Securities set a target price of $67.0 on 04/09/2026
- Seamus Fernandez from Guggenheim set a target price of $72.0 on 04/08/2026
- Carter Gould from Cantor Fitzgerald set a target price of $54.0 on 04/08/2026
- Rajesh Kumar from HSBC set a target price of $60.0 on 03/17/2026
- Trung Huynh from RBC Capital set a target price of $60.0 on 02/25/2026
- David Amsellem from Piper Sandler set a target price of $75.0 on 02/23/2026
- Emily Field from Barclays set a target price of $75.0 on 02/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
